Jason L Rucker1, Stephen D Jernigan, Joan M McDowd, Patricia M Kluding. 1. Department of Physical Therapy and Rehabilitation Science (J.L.R, S.D.J., P.M.K), University of Kansas Medical Center, Kansas City, Kansas; Department of Psychology, (J.M.M), University of Missouri-Kansas City, Kansas City, Missouri.
Abstract
BACKGROUND AND PURPOSE: Diabetic peripheral neuropathy (DPN) contributes to functional impairment, and there is growing evidence that neuropsychological factors also influence physical function. We compared cognitive and executive function in adults with DPN with an age-matched comparison group, and examined the relationships between DPN, executive function, and physical function. METHODS: Twenty subjects with DPN and 20 comparison subjects were assessed. Diabetic peripheral neuropathy was quantified via the Michigan Neuropathy Screening Instrument and nerve conduction velocity testing. Subjects were administered Beck's Depression Inventory, the Mini-Mental Status Examination, and the Timed Up and Go (TUG) test. Each participant also completed a battery of 7 executive function tasks, including the Cognitive Timed Up and Go (cTUG) test, in which a concurrent mental subtraction task was added to the standard TUG test. RESULTS: The DPN group demonstrated poorer letter fluency (34.2 ± 11.6 words vs 46.2 ± 12.2 words; P = 0.001), category fluency (47.0 ± 8.1 words vs 56.3 ± 8.5 words; P = 0.003), and Rey-Osterrieth scores (25.9 ± 4.3 points vs 31.7 ± 2.4 points; P < 0.001), and took longer to complete both the TUG (10.3 ± 2.8 seconds vs 5.9 ± 1.0 seconds; P < 0.001) and cTUG (13.0 ± 5.8 seconds vs 6.9 ± 1.6 seconds; P < 0.001). Poorer global cognitive performance and greater depression symptoms were significantly related to each other (r = -0.46; P = 0.04) and to slower TUG times (r = -0.53; P = 0.02; and r = 0.54; P = 0.02, respectively). DISCUSSION AND CONCLUSIONS: Verbal, visuospatial, and multitasking measures of executive function may be impaired in adults with DPN. Future research should examine how these and other cognitive and psychological factors, such as depression, affect physical function in this population.
BACKGROUND AND PURPOSE:Diabetic peripheral neuropathy (DPN) contributes to functional impairment, and there is growing evidence that neuropsychological factors also influence physical function. We compared cognitive and executive function in adults with DPN with an age-matched comparison group, and examined the relationships between DPN, executive function, and physical function. METHODS: Twenty subjects with DPN and 20 comparison subjects were assessed. Diabetic peripheral neuropathy was quantified via the Michigan Neuropathy Screening Instrument and nerve conduction velocity testing. Subjects were administered Beck's Depression Inventory, the Mini-Mental Status Examination, and the Timed Up and Go (TUG) test. Each participant also completed a battery of 7 executive function tasks, including the Cognitive Timed Up and Go (cTUG) test, in which a concurrent mental subtraction task was added to the standard TUG test. RESULTS: The DPN group demonstrated poorer letter fluency (34.2 ± 11.6 words vs 46.2 ± 12.2 words; P = 0.001), category fluency (47.0 ± 8.1 words vs 56.3 ± 8.5 words; P = 0.003), and Rey-Osterrieth scores (25.9 ± 4.3 points vs 31.7 ± 2.4 points; P < 0.001), and took longer to complete both the TUG (10.3 ± 2.8 seconds vs 5.9 ± 1.0 seconds; P < 0.001) and cTUG (13.0 ± 5.8 seconds vs 6.9 ± 1.6 seconds; P < 0.001). Poorer global cognitive performance and greater depression symptoms were significantly related to each other (r = -0.46; P = 0.04) and to slower TUG times (r = -0.53; P = 0.02; and r = 0.54; P = 0.02, respectively). DISCUSSION AND CONCLUSIONS: Verbal, visuospatial, and multitasking measures of executive function may be impaired in adults with DPN. Future research should examine how these and other cognitive and psychological factors, such as depression, affect physical function in this population.
Authors: H Thabit; S M Kennelly; A Bhagarva; M Ogunlewe; P M E McCormack; J H McDermott; S Sreenan Journal: Diabetes Res Clin Pract Date: 2009-09-26 Impact factor: 5.602
Authors: Peter Kokkinos; Jonathan Myers; Charles Faselis; Michael Doumas; Raya Kheirbek; Eric Nylen Journal: Diabetes Care Date: 2012-03-07 Impact factor: 19.112
Authors: Joshua I Barzilay; Alokananda Ghosh; Rodica Pop Busui; Andrew Ahmann; Ashok Balasubramanyam; Mary Ann Banerji; Robert M Cohen; Jennifer Green; Faramarz Ismail-Beigi; Catherine L Martin; Elizabeth Seaquist; José A Luchsinger Journal: J Diabetes Complications Date: 2021-09-15 Impact factor: 2.852
Authors: Jason L Rucker; Joan M McDowd; Jonathan D Mahnken; Jeffrey M Burns; Carla H Sabus; Amanda J Britton-Carpenter; Nora B Utech; Patricia M Kluding Journal: PLoS One Date: 2017-10-18 Impact factor: 3.240
Authors: Raghuveer Chandrashekhar; Hongwu Wang; Carol Dionne; Shirley James; Jenni Burzycki Journal: Int J Environ Res Public Health Date: 2021-03-02 Impact factor: 3.390